Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells

Life Sciences

Volumn 74, Issue 18, 2004, Pages 2279-2290

  Shieh, Den En ^a,c   Chen, Yuan Ying ^a   Yen, Ming Hong ^a   Chiang, Lien Chai ^b   Lin, Chun Ching ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

Author keywords

Apoptosis; Caspase 3; Emodin; Fas; Hepatoma cells; p21; p53; XTT

Indexed keywords

DNA FRAGMENT; EMODIN; PROTEIN DERIVATIVE; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DRUG ACTIVITY; DRUG EFFECT; FRAGMENTATION REACTION; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

EID: 1342324038     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.09.060     Document Type: Article

References (36)

1. Arichi H., Kimura Y., Okuda H., Baba K., Kozawa M., Archi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb. et Zucc. on lipid metabolism. Chemical Pharmaceutical Bulletin. 30:1982;1766-1770.
2. Barnard D.L., Huffman J.H., Morris J.L.B., Wood S.G., Hugh B.G., Sidwell R.W. Evaluation of the antiviral activity of anthraquinones, anthrones and anthrqinone derivatives against human cytomegalovirus. Antiviral Research. 17:1992;63-77.
3. 1 protects cells from apoptosis induced by UV-irradiation or RNA polymerase II blockage. Oncogene. 16:1998;3461-3469.
4. Chen C.H., Huang L.L.H., Huang C.C., Lin C.C., Lee Y., Lu F.J. Baicalein, a novel apoptotic agent for hepatoma cell lines: a potential medicine for hepatoma. Nutritional Cancer. 38:2000;287-295.
5. Cheng J., Zhou T., Liu C., Shapiro J.P., Brauer M.J., Kiefer M.C., Barr P.J., Mountz J.D. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
6. 1. Cancer Research. 57:1997;2550-2554.
7. Gan K.H., Fann Y.F., Hsu S.H., Kuo K.W., Lin C.N. Mediation of the cytotoicity of lanostaniods and steroids of Ganoderma tsugae through apoptosis and cell cycle. Journal of Natural Products. 61:1998;485-487.
8. 1. Molecullar Cancer Therapeutics. 1:2002;639-649.
9. Glaser T., Wagenknecht B., Weller M. Identification of p21 as a target of cycloheximide-mediated facilitation of CD95-mediated apoptosis in human malignant glioma cells. Oncogene. 20:2001;4757-4767.
10. Goodwin C.J., Holt S.J., Downes S., Marshall N.J. Microculture tetrazolium assays: a comparison between two new tetrazolium salt. XTT and MTS. Journal of Immunological Methods. 179:1995;95-103.
11. 2 checkpoint through cyclin B1. Proceedings of the Natural Academy of Sciences of the U.S.A. 96:1999;2147-2152.
12. Jayasuriya H., Koonchanok N.M., Geahlen R.L., McLaaughlin J.L., Chang C.J. Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum. Journal of Natural Products. 55:1992;696-698.
13. Kannan K., Amarigilio N., Rechavi G., Jakob-Hirsch J., Kela I., Kaminski N., Getz G., Domany E., Givol D. DNA microarrays identification of primary and secondary target genes regulated by p53. Oncogene. 20:2001;2225-2234.
14. Kaufmann S.H., Mesner P.W., Sameijima K., Tone S., Earnshaw W.C. Detection of DNA cleavage in apoptotic cells. Methods in Enzymology. 322:2000;3-15.
15. Kumar A., Dhawan S., Aggarwal B.B. Emodin (3-methyl-1,6,8-trihydroxy anthraquinone) inhibits TNF-induced NF-κB activation, IκB degradation, and expression of cell surface alhesion proteins in human vascular endothelial cells. Oncogene. 17:1998;913-918.
16. Kuo Y.C., Sun C.M., Ou J.C., Tsai W.J. A tumor cell growth inhibitor from Polygonum hypoleucum Ohwi. Life Sciences. 61:1997;2335-2344.
17. Kuo Y.C., Meng H.C., Tsai W.J. Regulation of cell proliferation, inflammatory cytokine production and calcium mobilization in primary human T lymphocytes by emodin from Polygonum hypoleucum Ohwi. Inflammation Research. 50:2001;073-082.
18. Kuo P.L., Chiang L.C., Lin C.C. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sciences. 72:2002;23-34.
19. Lee H.Z. Effects and mechanisms of emodin on cell death in human lung squamous cell carcinoma. British Journal of Pharmacology. 134:2001;11-20.
20. Lee H.Z. Protein kinase C involvement in aloe-emodin- and emodin-induced apoptosis in lung carcinoma cell. British Journal of Pharmacology. 134:2001;1093-1103.
21. Lin C.C., Chang C.H., Yang J.J., Namba T., Hattori M. Hepatoprotective effects of emodin from Ventilago leiocarpa. Journal of Ethnopharmacology. 52:1996;107-111.
22. Mediavilla M.D., Cos S., Sanchez-Barcelo E.J. Menatonin increases p53 and p21WAF1 expression in MCF-7 human breast cancer cells in vitro. Life Sciences. 65:1999;415-420.
23. Munsch D., Watanabe-Fukunaga R., Bourdon J.C., Nagata S., May E., Yonish-Rouach E., Reiadorf P. Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis. The Journal of Biological Chemistry. 275:2000;3867-3872.
24. O'Connor L., Strasser A. Fas, p53, and apoptosis. Science. 284:1999;1431b.
25. Qin L.F., Ng I.O.L. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Letter. 175:2002;27-38.
26. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-3400.
27. Robinow S., Talbot W.S., Hogness D.S., Truman J.W. Programmed cell death in the Drosophila CNS is ecdysone-regulated and coupled with a specific ecdysone receptor isoform. Development. 119:1993;1251-1259.
28. Scudiero D.A., Shoemaker R.H., Kenneth D.P., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., Boyd M.R. Evaluation of a soluble tetrazolium /formazane assay for cell growth and drug sensitivity in culture using human and other tumor cell Lines. Cancer Research. 48:1988;4827-4833.
29. Steller H. Mechasims and genes of cellular suicide. Science. 267:1995;1445-1449.
30. 2/M transition by p53. Oncogene. 20:2001;1803-1815.
31. Yeh S.F., Chou T.C., Liu T.S. Effects of anthraquinones of Polygonum cuspidatum on HL-60 cells. Planta Medica. 10:1988;413-414.
32. Yu J., Zhang L., Hwang P.M., Rago C., Kinzler K.W., Vogelstein B. Identification and classification of p53-regulated genes. Proceedings of the Natural Academy of Sciences of the U.S.A. 96:1999;14517-14522.
33. Zhang L., Hung M.C. Sensitization of HER-2/neu- overexpressing non-small cell lung cancer cells to chemotherapeutic drugs by tyrosine kinase inhibitor emodin. Oncogene. 12:1996;571-576.
34. Zhang L., Lau Y.K., Xi L., Hong R.L., Kim D.S.H.L., Chan C.F., Hortobagyi G.N., Chang C.J., Hung M.C. Tyrosine kinase inhibitors, emodin and its derivatives repress HER-2/neu-induced cellular transformation and metastasis-associated properties. Oncogene. 16:1998;2855-2863.
35. 1. Clinical Cancer Research. 5:1999;343-353.
36. Waf1/Cip1 converts cancer cells from growth arrest to undergoing apoptosis. Oncogene. 18:1999;1131-1138.